Expert panel recommends permission for phase 1 clinical trial of Bharat Biotech's nasal vaccine
Tuesday, 19 January 2021 An expert panel of India's drug regulator CDSCO on Tuesday recommended granting permission for conducting phase 1 clinical trial of an intranasal vaccine against Covid-19 developed by Bharat Biotech, official sources said.
"We are not utilising it fully. We are either donating it to foreign countries or selling it to foreign countries and are not vaccinating our own people. So.. IndiaTimes
This interim efficacy trend puts Covaxin at par with other global front-runner vaccines, the desi vaccine’s co-developer, the Indian Council for Medical.. IndiaTimes
Arvind Kejriwal slams BJP saying the party has failed to govern the municipal corporations in Delhi. Karnataka Minister resigns on moral grounds after tape scandal. Maharashtra Chief Minister Uddhav Thackeray slams BJP and RSS. In a statement made by Bharat Biotech, the biotechnology company claims that the Covaxin is 81 percent effective in preventing Covid and can work against the UK variant of the virus. TMC meets Election Commission over PM's photo on vaccine documents
#PMModi #ArvindKejriwal #KarnatakaMinisterSexTape
Bharat Biotech's COVID-19 vaccine, 'COVAXIN' has demonstrated an interim vaccine efficacy of 80.6% in its Phase 3 clinical trial. "Today is an important day for us, country and Indian science. COVAXIN has demonstrated an interim vaccine efficacy of around 80.6% in its Phase 3 clinical trial. The trials involved 25,800 subjects, the largest ever conducted in India, in partnership with ICMR," Bharat Biotech chairman Dr Krishna Ella.
CNN’s Dana Bash says that Sen. Ron Johnson (R-WI) is doing everything in his power to delay President Joe Biden’s Covid-19 stimulus relief bill because Johnson believes that fighting Biden’s agenda will help get him reelected.
TV presenter Chris Kamara has urged people from black, Asian and minority ethnic (BAME) communities to get the Covid-19 vaccine.The Sky Sports analyst said he was “feeling great” after getting his first jab and hoped it would accelerate a return to normal life.The 63-year-old said he understands why some people in minority communities may be reluctant to have the vaccination, and revealed that his Sierra Leone-born father was hesitant about needles.
Credit: PA - Press Association STUDIO Duration: 01:40Published
With the 2nd phase of vaccination being kicked off in India from March 1st, designated inoculation centres are brimming with people waiting to get the jab. We visited Max Smart Super Speciality Hospital in Saket to show you what to expect.
#CovidVaccine #MaxHospital #CoWin
As second phase of vaccination of COVID-19 is underway in India, Delhi Lieutenant Governor Anil Baijal took the first dose of COVID-19 vaccine at Tirath Ram Shah Hospital. Union Tourism Minister Prahlad Singh Patel also received the first dose on March 04 in Delhi.
The one-dose Johnson & Johnson Covid-19 vaccine is administered in the United States for the first time outside of a clinical trial at a mass vaccination site in Columbus, Ohio.
India's second phase of the vaccination drive began today, opening registerations for people above 60 years and those aged 45 in the second phase of the inoculation drive. In the second phase, Prime..
Phase 2 of India's Covid-19 vaccination drive was launched in high-profile manner on March 1 with Prime Minister Narendra Modi becoming one of the first beneficiaries. The second phase of the programme..
Credit: HT Digital Content Duration: 04:31Published
AS India is all set to begin vaccinations against COVID-19, health experts have raised concerns about allergic reactions as a side effect. Allergic reactions to... Mid-Day
Covid-19 positive cases are hovering between 100 and 200 during the last one week. Thirteen people have lost their lives due to Covid in the last two weeks. Only... IndiaTimes Also reported by •Mid-Day
With the UK giving the green light to the Covid-19 vaccine developed by Oxford University and drug maker AstraZeneca, India is also expected to follow suit soon... Mid-Day Also reported by •IndiaTimes